Patients who require insulin glargine to improve metabolic control and to avoid microvascular and macrovascular complications of diabetes mellitus should, therefore, continue their treatment with ...

The gold standard treatment for type 1 diabetes mellitus is intensive insulin replacement ... and every 3 months thereafter. The therapy resulted in various periods (1–35 months) of insulin ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, drug interactions, and role in therapy of vildagliptin for the treatment of type 2 diabetes mellitus were reviewed.

GDM is managed with medical nutritional therapy (MNT), exercise ... GDM should be differentiated from types 1 and 2 diabetes mellitus. Treatment options should be discussed.

A newly designed therapy following an islet cell transplant could mean people with type 1 diabetes no longer need to inject ...

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

The AYUSH ministry aims to combine traditional and modern medicine in order to make treatments more effective and improve ...

Researchers has discovered a specific protein IL-35 that protects the immune system by lowering particular immune cells that produce inflammatory chemicals, thereby reducing pancreatic cell ...

Alnylam Pharmaceuticals will suspend further clinical development of its potential treatment for type 2 diabetes mellitus.

IL-35, a protein composed of IL-12α and IL-27β chains encoded by the IL12A and EBI3 genes, has intrigued scientists as a potential therapeutic pathway.